speb/financial-data huggingface dataset:
DuPont ROE decomposition for 9989.HK (annual period ending 2024-12-31)
ROE: 5.2771840139602535%
Net margin: 12.247240404436605%
Asset turnover: 0.28498098552147055
Equity multiplier (leverage): 1.5119871887302228
EBIT margin: 14.06073736479318%
Interest burden factor: 0.9780770003275344
Tax burden factor: 0.8905475229812457
ROE archetype: Standard Business
DuPont ROE decomposition for 9989.HK (annual period ending 2025-12-31)
ROE: 2.9392229699099883%
Net margin: 6.378663155883111%
Asset turnover: 0.32943859065455267
Equity multiplier (leverage): 1.3987122969712844
EBIT margin: 11.607444763600075%
Interest burden factor: 0.6324826127224737
Tax burden factor: 0.8688492926049213
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (annual period ending 2022-12-31)
ROE: -10.752953752930146%
Net margin: -7.265811342028949%
Asset turnover: 0.8298993229913253
Equity multiplier (leverage): 1.7832747098569537
EBIT margin: 0.5528394236099645%
Interest burden factor: -12.495327505275398
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (annual period ending 2023-12-31)
ROE: -3.8243464666800597%
Net margin: -2.5280943185172333%
Asset turnover: 0.8466941657731044
Equity multiplier (leverage): 1.7866413884753487
EBIT margin: -1.942439258770953%
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (annual period ending 2024-12-31)
ROE: -2.347741675671518%
Net margin: -1.4686970567155608%
Asset turnover: 0.8990082202784258
Equity multiplier (leverage): 1.7780927943266722
EBIT margin: -1.1450687517783742%
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (annual period ending 2025-12-31)
ROE: -3.6173448174990823%
Net margin: -2.006740145249859%
Asset turnover: 1.0211675228521242
Equity multiplier (leverage): 1.765231936817651
EBIT margin: 0.7536084471714446%
Interest burden factor: -2.6786257505003337
ROE archetype: Low Return
DuPont ROE decomposition for 9994.T (annual period ending 2022-03-31)
ROE: 18.685097311051507%
Net margin: 3.7888718449309717%
Asset turnover: 2.3520343736162816
Equity multiplier (leverage): 2.0967264974898563
EBIT margin: 0.4483335657509413%
Interest burden factor: 10.640746500777604
Tax burden factor: 0.7942122186495176
ROE archetype: Balanced Compounder
DuPont ROE decomposition for 9994.T (annual period ending 2023-03-31)
ROE: 6.293038577162401%
Net margin: 1.263386661778953%
Asset turnover: 2.4279282043375434
Equity multiplier (leverage): 2.0515791009816393
EBIT margin: 1.8577675368542323%
Interest burden factor: 0.8481324876673715
Tax burden factor: 0.8018280016618197
ROE archetype: Standard Business
DuPont ROE decomposition for 9994.T (annual period ending 2024-03-31)
ROE: 12.331032387432614%
Net margin: 2.583341129510088%
Asset turnover: 2.470303950272967
Equity multiplier (leverage): 1.9322676684934266
EBIT margin: 3.941123273146849%
Interest burden factor: 0.8415888589966767
Tax burden factor: 0.7788642346746897
ROE archetype: Standard Business
DuPont ROE decomposition for 9994.T (annual period ending 2025-03-31)
ROE: 12.820921537739189%
Net margin: 2.8202342598836196%
Asset turnover: 2.490695446967412
Equity multiplier (leverage): 1.8252124877413216
EBIT margin: 3.3877775280337654%
Interest burden factor: 0.969590858827866
Tax burden factor: 0.8585820186276373
ROE archetype: Standard Business
DuPont ROE decomposition for 9994.T (annual period ending 2026-03-31)
ROE: 6.424100751802533%
Net margin: 1.6038310949666603%
Asset turnover: 2.3314896640912592
Equity multiplier (leverage): 1.7179883709094397
EBIT margin: 2.244860764584996%
Interest burden factor: 0.9356103023516238
Tax burden factor: 0.7636146020347098
ROE archetype: Standard Business
DuPont ROE decomposition for A8G.AX (annual period ending 2021-06-30)
ROE: -16.527635767074873%
Equity multiplier (leverage): 1.052091804834392
ROE archetype: Low Return
DuPont ROE decomposition for A8G.AX (annual period ending 2022-06-30)
ROE: -14.445585209621688%
Equity multiplier (leverage): 1.0446113789894889
ROE archetype: Low Return
DuPont ROE decomposition for A8G.AX (annual period ending 2023-06-30)
ROE: -3.3503577258511044%
Equity multiplier (leverage): 1.0344812491824873
ROE archetype: Low Return
DuPont ROE decomposition for A8G.AX (annual period ending 2024-06-30)
ROE: -4.705192943976324%
Equity multiplier (leverage): 1.0313468989381873
ROE archetype: Low Return
DuPont ROE decomposition for AA4.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 3.641830512612361
ROE archetype: Standard Business
DuPont ROE decomposition for AA4.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 3.6646719517059516
ROE archetype: Standard Business
DuPont ROE decomposition for AA4.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 3.611549850879296
ROE archetype: Standard Business
DuPont ROE decomposition for AAA.PA (annual period ending 2022-12-31)
ROE: 20.646025305322908%
Net margin: 3.2210784329012156%
Asset turnover: 1.0012083101766567
Equity multiplier (leverage): 6.401926882408202
EBIT margin: 6.9180369789409015%
Interest burden factor: 0.7084385142445006
Tax burden factor: 0.6572283023670146
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for AAA.PA (annual period ending 2023-12-31)
ROE: 11.6181376346526%
Net margin: 1.817550232219736%
Asset turnover: 1.0639672177637318
Equity multiplier (leverage): 6.007888273331181
EBIT margin: 6.328192952992598%
Interest burden factor: 0.4861255186721992
Tax burden factor: 0.5908242197919445
ROE archetype: Standard Business
DuPont ROE decomposition for AAA.PA (annual period ending 2024-12-31)
ROE: -17.066813296041534%
Net margin: -2.8744229782868866%
Asset turnover: 0.9955073948918336
Equity multiplier (leverage): 5.964269664109464
EBIT margin: 5.606460506069413%
Interest burden factor: -0.29194263115261826
ROE archetype: Low Return
DuPont ROE decomposition for AAA.PA (annual period ending 2025-12-31)
ROE: -20.86135516382234%
Net margin: -2.843490023877327%
Asset turnover: 1.0717750165181397
Equity multiplier (leverage): 6.8452163471489955
EBIT margin: 4.8302409824506185%
Interest burden factor: -0.4713990351481737
ROE archetype: Low Return
DuPont ROE decomposition for AAL.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.0320655967805554
ROE archetype: Standard Business
DuPont ROE decomposition for AAPG (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 9.548405687148472
ROE archetype: Standard Business
DuPont ROE decomposition for AAPG (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 5.943083836662579
ROE archetype: Standard Business
DuPont ROE decomposition for AAPG (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.47901995947444
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIDRUGS.NS (annual period ending 2023-03-31)
ROE: 13.948324261236152%
Net margin: 6.14869825106582%
Asset turnover: 1.1173576489814854
Equity multiplier (leverage): 2.0302365788299843
EBIT margin: 9.844495488155943%
Interest burden factor: 0.8416839528514227
Tax burden factor: 0.7420628141140617
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIDRUGS.NS (annual period ending 2024-03-31)
ROE: 13.763800815750878%
Net margin: 6.839359762965873%
Asset turnover: 1.0257449211032252
Equity multiplier (leverage): 1.9619302109727248
EBIT margin: 11.068864128037204%
Interest burden factor: 0.848126869124804
Tax burden factor: 0.7285369285494112
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIDRUGS.NS (annual period ending 2025-03-31)
ROE: 12.528922069547738%
Net margin: 7.044737602795105%
Asset turnover: 0.9416759236869467
Equity multiplier (leverage): 1.8886323298332894
EBIT margin: 9.689027787669197%
Interest burden factor: 0.9156433759944655
Tax burden factor: 0.7940690371629598
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIDRUGS.NS (annual period ending 2026-03-31)
ROE: 12.742176417186396%
Net margin: 7.599081592478102%
Asset turnover: 0.9072052843138304
Equity multiplier (leverage): 1.8483190292535938
EBIT margin: 9.442523515676468%
Interest burden factor: 0.87066011641828
Tax burden factor: 0.9243243243243243
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIIND.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.9360646702186293
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIIND.NS (quarterly period ending 2024-12-31)
Net margin: 2.4959305480195333%
EBIT margin: 6.782419967444383%
Interest burden factor: 0.32000000000000006
Tax burden factor: 1.15
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIIND.NS (quarterly period ending 2025-03-31)
ROE: 1.7126892432411223%
Net margin: 4.925602873268343%
Asset turnover: 0.17537197935487586
Equity multiplier (leverage): 1.9827089748484452
EBIT margin: 8.004104669061057%
Interest burden factor: 0.5641025641025641
Tax burden factor: 1.0909090909090908
ROE archetype: Low Return
DuPont ROE decomposition for AARTIIND.NS (quarterly period ending 2025-06-30)
Net margin: 2.5671641791044775%
EBIT margin: 4.835820895522388%
Interest burden factor: 0.5185185185185185
Tax burden factor: 1.0238095238095237
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIIND.NS (quarterly period ending 2025-12-31)
Net margin: 5.737704918032787%
EBIT margin: 8.843830888697154%
Interest burden factor: 0.5756097560975609
Tax burden factor: 1.1271186440677967
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIIND.NS (quarterly period ending 2026-03-31)
ROE: 2.3005877413937865%
Net margin: 6.213151927437641%
Asset turnover: 0.1658019399954884
Equity multiplier (leverage): 2.2332493702770777
EBIT margin: 9.795918367346939%
Interest burden factor: 0.513888888888889
Tax burden factor: 1.2342342342342343
ROE archetype: Low Return
DuPont ROE decomposition for AARTIPHARM.NS (annual period ending 2023-03-31)
ROE: 12.415474088773044%
Net margin: 9.994475735980988%
Asset turnover: 0.8627379531357912
Equity multiplier (leverage): 1.4398736569181922
EBIT margin: 14.437404458512365%
Interest burden factor: 0.932975276628142
Tax burden factor: 0.7419946252475316
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIPHARM.NS (annual period ending 2024-03-31)
ROE: 12.988096846479966%
Net margin: 11.947203456095856%
Asset turnover: 0.7469081321751142
Equity multiplier (leverage): 1.4554995339727477
EBIT margin: 17.23000848469065%
Interest burden factor: 0.9606162429346473
Tax burden factor: 0.7218232099357054
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIPHARM.NS (annual period ending 2025-03-31)
ROE: 14.366408232899925%
Net margin: 12.87920590976819%
Asset turnover: 0.7614915593135935
Equity multiplier (leverage): 1.4648529251511313
EBIT margin: 17.846496660046725%
Interest burden factor: 0.9555531653520695
Tax burden factor: 0.755233518025892
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIPHARM.NS (annual period ending 2026-03-31)
ROE: 8.088882005415678%
Net margin: 9.602243544382413%
Asset turnover: 0.5441087877511722
Equity multiplier (leverage): 1.548210623822882
EBIT margin: 16.38318331027224%
Interest burden factor: 0.7813981762102183
Tax burden factor: 0.7500704100786016
ROE archetype: Standard Business
DuPont ROE decomposition for AATG.L (annual period ending 2022-12-31)
ROE: -5.196829612279068%
Asset turnover: -0.04612140481074941
Equity multiplier (leverage): 1.009105379926926
ROE archetype: Low Return
DuPont ROE decomposition for AATG.L (annual period ending 2023-12-31)
ROE: 3.5818199118952174%
Net margin: 87.09677419354837%
Asset turnover: 0.04076455948468066
Equity multiplier (leverage): 1.0088321696173663
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for AATG.L (annual period ending 2024-12-31)
ROE: 6.010724353229889%
Net margin: 91.34361761649748%
Asset turnover: 0.0651313509712991
Equity multiplier (leverage): 1.010318994249009
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for AATG.L (annual period ending 2025-12-31)
ROE: 1.8537899793025343%
Net margin: 82.72917392819798%
Asset turnover: 0.022218706045947865
Equity multiplier (leverage): 1.0085166653649391
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for AAU.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0503605409265786
ROE archetype: Standard Business
DuPont ROE decomposition for AAU.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.052873057090079
ROE archetype: Standard Business
DuPont ROE decomposition for AAU.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0394587695741944
ROE archetype: Standard Business
DuPont ROE decomposition for ABBV (annual period ending 2022-12-31)
ROE: 68.5196968820501%
Net margin: 20.40341750783753%
Asset turnover: 0.4182414178163611
Equity multiplier (leverage): 8.029444090935385
EBIT margin: 32.407758294002136%
Interest burden factor: 0.716328266184756
Tax burden factor: 0.8789048007716851
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ABBV (annual period ending 2023-12-31)
ROE: 35.20445022395607%
Net margin: 8.971243418388012%
Asset turnover: 0.39718334576405034
Equity multiplier (leverage): 9.879930645860425
EBIT margin: 24.918075039581723%
Interest burden factor: 0.46176579239009974
Tax burden factor: 0.77968
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ABBV (annual period ending 2024-12-31)
ROE: 62.29198459414287%
Net margin: 7.608193985869989%
Asset turnover: 0.41748680856109566
Equity multiplier (leverage): 19.611365453092073
EBIT margin: 21.113359605211773%
Interest burden factor: 0.3124264334958803
Tax burden factor: 1.1533907427341228
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ABBV (annual period ending 2025-12-31)
ROE: 6225%
Net margin: 6.921190320470896%
Asset turnover: 0.4545167415400508
Equity multiplier (leverage): 1978.8308823529412
EBIT margin: 32.849901896664484%
Interest burden factor: 0.32835598028968194
Tax burden factor: 0.6416552978626648
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ABCB (annual period ending 2022-12-31)
ROE: 10.83818102208044%
Net margin: 33.048314587453966%
Asset turnover: 0.041854230219540864
Equity multiplier (leverage): 7.8355182335647715
Tax burden factor: 0.7648235039660294
ROE archetype: Standard Business
DuPont ROE decomposition for ABCB (annual period ending 2023-12-31)
ROE: 8.124970656599258%
Net margin: 25.813206408769613%
Asset turnover: 0.04148712860510832
Equity multiplier (leverage): 7.586936853907378
Tax burden factor: 0.75393278888313
ROE archetype: Standard Business
DuPont ROE decomposition for ABCB (annual period ending 2024-12-31)
ROE: 9.9936349557254%
Net margin: 32.495381875207805%
Asset turnover: 0.04289466378892105
Equity multiplier (leverage): 7.169660122795621
Tax burden factor: 0.7537616105577271
ROE archetype: Standard Business
DuPont ROE decomposition for ABCB (annual period ending 2025-12-31)
ROE: 10.530855759464968%
Net margin: 35.116266388567965%
Asset turnover: 0.04364928221761757
Equity multiplier (leverage): 6.870339889237373
Tax burden factor: 0.772165226579537
ROE archetype: Standard Business
DuPont ROE decomposition for ABEO.PA (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.835765358237268
ROE archetype: Standard Business
DuPont ROE decomposition for ABEO.PA (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 2.7356323799363427
ROE archetype: Standard Business
DuPont ROE decomposition for ABEO.PA (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 2.873444768317783
ROE archetype: Standard Business
DuPont ROE decomposition for ABEV (annual period ending 2022-12-31)
ROE: 17.87062660960688%
Net margin: 11.827123468713465%
Asset turnover: 0.9126487771640645
Equity multiplier (leverage): 1.6556059322339005
EBIT margin: 13.821846566359985%
Interest burden factor: 0.8180109982933682
Tax burden factor: 1.046053555874006
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ABEV (annual period ending 2023-12-31)
ROE: 19.096095371766477%
Net margin: 12.454783932759286%
Asset turnover: 0.9262370390677509
Equity multiplier (leverage): 1.655336279142595
EBIT margin: 15.628587626969214%
Interest burden factor: 0.8009449892663283
Tax burden factor: 0.9949786843487919
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ABEV (annual period ending 2024-12-31)
ROE: 14.72162791600398%
Net margin: 11.068963229203712%
Asset turnover: 0.8091697508214575
Equity multiplier (leverage): 1.6436496552451485
EBIT margin: 16.034187498928286%
Interest burden factor: 0.9060994662153364
Tax burden factor: 0.7618756831372228
ROE archetype: Standard Business
DuPont ROE decomposition for ABEV (annual period ending 2025-12-31)
ROE: 18.05823943665138%
Net margin: 12.172113706075322%
Asset turnover: 0.9084229865527359
Equity multiplier (leverage): 1.6331320107706804
EBIT margin: 16.994397526659142%
Interest burden factor: 0.8700464999596821
Tax burden factor: 0.8232235077258943
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ABF.L (quarterly period ending 2025-02-28)
Equity multiplier (leverage): 1.6834564786448007
ROE archetype: Standard Business
DuPont ROE decomposition for ABF.L (quarterly period ending 2025-08-31)
Equity multiplier (leverage): 1.7047642564632546
ROE archetype: Standard Business
DuPont ROE decomposition for ABF.L (quarterly period ending 2026-02-28)
Equity multiplier (leverage): 1.706586563760744
ROE archetype: Standard Business
DuPont ROE decomposition for ABFRL.NS (annual period ending 2023-03-31)
ROE: -1.0759115361625824%
Net margin: -0.2911945203662256%
Asset turnover: 0.7254660448041462
Equity multiplier (leverage): 5.0930304841601926
EBIT margin: 2.734073884138553%
Interest burden factor: -0.2438981095233869
ROE archetype: Low Return
DuPont ROE decomposition for ABFRL.NS (annual period ending 2024-03-31)
ROE: -15.491014664344474%
Net margin: -9.83537238540903%
Asset turnover: 0.32122036985459307
Equity multiplier (leverage): 4.903271930979781
EBIT margin: -9.651982985974078%
ROE archetype: Low Return
DuPont ROE decomposition for ABFRL.NS (annual period ending 2025-03-31)
ROE: -6.454989672628288%
Net margin: -5.1099088613722055%
Asset turnover: 0.37083441109206106
Equity multiplier (leverage): 3.406452758143569
EBIT margin: -6.662107242550032%
ROE archetype: Low Return
DuPont ROE decomposition for ABFRL.NS (annual period ending 2026-03-31)
ROE: -11.262160620205849%
Net margin: -9.488780616662508%
Asset turnover: 0.4528594918350974
Equity multiplier (leverage): 2.620884221766537
EBIT margin: -7.9843021577806805%
ROE archetype: Low Return
DuPont ROE decomposition for ABO.DE (annual period ending 2022-12-31)
ROE: 13.66921237071094%
Net margin: 32.715357817032185%
Asset turnover: 0.14436628299859308
Equity multiplier (leverage): 2.8941833548147153
EBIT margin: 46.30519191516137%
Interest burden factor: 0.8729285430200185
Tax burden factor: 0.8093628977143292
ROE archetype: Standard Business
DuPont ROE decomposition for ABO.DE (annual period ending 2023-12-31)
ROE: 4.433465831377802%
Net margin: 15.247206797350637%
Asset turnover: 0.11277565367770875
Equity multiplier (leverage): 2.5783253701367057
EBIT margin: 22.59539260944225%
Interest burden factor: 0.8260955388866956
Tax burden factor: 0.8168458781362007
ROE archetype: Low Return
DuPont ROE decomposition for ABO.DE (annual period ending 2024-12-31)
ROE: 0.43952228056212717%
Net margin: 2.006485048360724%
Asset turnover: 0.09452446376846016
Equity multiplier (leverage): 2.317398627079713
EBIT margin: 12.986725050577833%
Interest burden factor: 0.3958600085360649
Tax burden factor: 0.3902964959568733
ROE archetype: Low Return
DuPont ROE decomposition for ABO.DE (annual period ending 2025-12-31)
ROE: -7.190962282156048%
Net margin: -27.27971786916978%
Asset turnover: 0.10170781118781204
Equity multiplier (leverage): 2.591748334959218
EBIT margin: 16.919894996420332%
Interest burden factor: -1.926187118006582
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (annual period ending 2022-10-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ABR.V (annual period ending 2023-10-31)
ROE: -25.003491255682537%
Asset turnover: 0
Equity multiplier (leverage): 1.588252174426399
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (annual period ending 2024-10-31)
ROE: -20.922027428691564%
Asset turnover: 0
Equity multiplier (leverage): 1.1287385646176185
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (annual period ending 2025-10-31)
ROE: 3.711187766012968%
Asset turnover: 0
Equity multiplier (leverage): 1.030596336708702
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for ABV.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.3802331002331
ROE archetype: Standard Business
DuPont ROE decomposition for ABX.AX (annual period ending 2022-12-31)
ROE: -24.98027118157687%
Net margin: -6217.857142857143%
Asset turnover: 0.00328426485250132
Equity multiplier (leverage): 1.223258483391922
EBIT margin: -9419.642857142857%
ROE archetype: Low Return
DuPont ROE decomposition for ABX.AX (annual period ending 2023-12-31)
ROE: -12.349579135447804%
Net margin: -736.4864864864865%
Asset turnover: 0.011545488119806577
Equity multiplier (leverage): 1.4523626646470202
EBIT margin: -1469.369369369369%
ROE archetype: Low Return
DuPont ROE decomposition for ABX.AX (annual period ending 2024-12-31)
ROE: -15.850726859501666%
Net margin: -3451.724137931035%
Asset turnover: 0.002673126617434164
Equity multiplier (leverage): 1.7178829617104718
EBIT margin: -7946.551724137932%
ROE archetype: Low Return
DuPont ROE decomposition for ABX.AX (annual period ending 2025-12-31)
ROE: -55.96625641971132%
Net margin: -5623.478260869566%
Asset turnover: 0.005937644312176098
Equity multiplier (leverage): 1.6761275296195652
EBIT margin: -3579.130434782609%
ROE archetype: Low Return
DuPont ROE decomposition for ABY.AX (annual period ending 2022-06-30)
ROE: 6.369580363363525%
Net margin: 1.1905238906140438%
Asset turnover: 3.3710407239819005
Equity multiplier (leverage): 1.5871161369848332
EBIT margin: 1.878693779425023%
Interest burden factor: 0.8816315649160222
Tax burden factor: 0.7187783489567585
ROE archetype: Standard Business
DuPont ROE decomposition for ABY.AX (annual period ending 2023-06-30)
ROE: -1.4890943199929678%
Net margin: -0.3095443772565176%
Asset turnover: 2.910601514820495
Equity multiplier (leverage): 1.6527856608970959
EBIT margin: -0.8228675216514941%
ROE archetype: Low Return
DuPont ROE decomposition for ABY.AX (annual period ending 2024-06-30)
ROE: 5.752206654537278%
Net margin: 1.1112871003837133%
Asset turnover: 3.018871542149594
Equity multiplier (leverage): 1.7146029773285032
EBIT margin: 1.1725994921290217%
Interest burden factor: 1.2309368191721133
Tax burden factor: 0.7699115044247788
ROE archetype: Standard Business
DuPont ROE decomposition for ABY.AX (annual period ending 2025-06-30)
ROE: 1.885999391325295%
Net margin: 0.3827678998063527%
Asset turnover: 2.601808355938219
Equity multiplier (leverage): 1.8937852726495887
EBIT margin: 2.045620300279154%
Interest burden factor: 0.3029259896729776
Tax burden factor: 0.6176948051948052
ROE archetype: Low Return
DuPont ROE decomposition for ABZ.V (annual period ending 2022-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ABZ.V (annual period ending 2023-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ABZ.V (annual period ending 2024-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ABZ.V (annual period ending 2025-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACEINTEG.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.0890518596123624
ROE archetype: Standard Business
DuPont ROE decomposition for ACEINTEG.NS (quarterly period ending 2024-12-31)
Net margin: -14.685314685314687%
EBIT margin: -23.076923076923077%
ROE archetype: Standard Business
DuPont ROE decomposition for ACEINTEG.NS (quarterly period ending 2025-03-31)
ROE: -7.8677309007981755%
Net margin: -95.83333333333334%
Asset turnover: 0.07907742998352553
Equity multiplier (leverage): 1.0381984036488028
EBIT margin: -148.61111111111114%
ROE archetype: Low Return
DuPont ROE decomposition for ACEINTEG.NS (quarterly period ending 2025-06-30)
Net margin: -68.18181818181817%
EBIT margin: -109.09090909090911%
ROE archetype: Standard Business
DuPont ROE decomposition for ACEINTEG.NS (quarterly period ending 2025-09-30)
ROE: -0.23255813953488377%
Net margin: -23.529411764705884%
Asset turnover: 0.009631728045325779
Equity multiplier (leverage): 1.0261627906976745
EBIT margin: -223.52941176470588%
ROE archetype: Low Return
DuPont ROE decomposition for ACEINTEG.NS (quarterly period ending 2025-12-31)
Net margin: -245.45454545454547%
EBIT margin: -363.6363636363637%
ROE archetype: Standard Business
DuPont ROE decomposition for ACEINTEG.NS (quarterly period ending 2026-03-31)
ROE: -2.037147992810066%
Net margin: -377.7777777777778%
Asset turnover: 0.00529723366686286
Equity multiplier (leverage): 1.017974835230677
EBIT margin: -500%
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (quarterly period ending 2025-03-31)
ROE: -9.23563729852665%
Asset turnover: 0
Equity multiplier (leverage): 1.2010283793137546
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (quarterly period ending 2025-06-30)
ROE: -15.303469281628407%
Asset turnover: 0
Equity multiplier (leverage): 1.1711239878166555
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (quarterly period ending 2025-09-30)
ROE: -7.789637802830415%
Asset turnover: 0
Equity multiplier (leverage): 1.1507255936675462
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (quarterly period ending 2025-12-31)
ROE: -9.794923647299784%
Net margin: -62966.666666666664%
Asset turnover: 0.00013744130111098386
Equity multiplier (leverage): 1.1318088719504291
EBIT margin: -78133.33333333334%
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (quarterly period ending 2026-03-31)
ROE: -10.167670823408528%
Net margin: -13606.25%
Asset turnover: 0.0006682398145634515
Equity multiplier (leverage): 1.118280323198356
EBIT margin: -15912.5%
ROE archetype: Low Return
DuPont ROE decomposition for ACM (annual period ending 2022-09-30)
ROE: 12.846576256275958%
Net margin: 2.5456142910099664%
Asset turnover: 1.180340263292671
Equity multiplier (leverage): 4.275506557779118
EBIT margin: 5.328987688183811%
Interest burden factor: 0.7859419265983031
Tax burden factor: 0.6077954245826085
ROE archetype: Standard Business
DuPont ROE decomposition for ACM (annual period ending 2023-09-30)
ROE: 4.014399419533421%
Net margin: 0.6964653588447332%
Asset turnover: 1.2853569435231211
Equity multiplier (leverage): 4.48432740239202
EBIT margin: 5.507473991827081%
Interest burden factor: 0.2694818724822892
Tax burden factor: 0.46926429240862233
ROE archetype: Low Return
DuPont ROE decomposition for ACM (annual period ending 2024-09-30)
ROE: 19.362359519246567%
Net margin: 2.8577508127969717%
Asset turnover: 1.3827389292333867
Equity multiplier (leverage): 4.899973517712318
EBIT margin: 5.738636582364606%
Interest burden factor: 0.7770223189748073
Tax burden factor: 0.640888001425882
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ACM (annual period ending 2025-09-30)
ROE: 25.113004910202%
Net margin: 3.9417713748190635%
Asset turnover: 1.330448977694179
Equity multiplier (leverage): 4.7886051260472025
EBIT margin: 6.560649313843905%
Interest burden factor: 0.8646710059082187
Tax burden factor: 0.6948542381841237
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ACR (annual period ending 2022-12-31)
ROE: 2.4071296174605834%
Net margin: 13.788940809968848%
Asset turnover: 0.032415347303686025
Equity multiplier (leverage): 5.385399058266903
Tax burden factor: 0.9870841850957072
ROE archetype: Low Return
DuPont ROE decomposition for ACR (annual period ending 2023-12-31)
ROE: 5.045468936789671%
Net margin: 24.369802777656844%
Asset turnover: 0.04018407275960651
Equity multiplier (leverage): 5.1522338988359815
Tax burden factor: 1.0202779676463887
ROE archetype: Standard Business
DuPont ROE decomposition for ACR (annual period ending 2024-12-31)
ROE: 6.533709426628878%
Net margin: 29.375395208318693%
Asset turnover: 0.04886780662610004
Equity multiplier (leverage): 4.551486420568895
Tax burden factor: 1.0154748273828111
ROE archetype: Standard Business
DuPont ROE decomposition for ACR (annual period ending 2025-12-31)
ROE: 5.593779180088258%
Net margin: 30.53481772538747%
Asset turnover: 0.04531346636395042
Equity multiplier (leverage): 4.042804127751551
Tax burden factor: 1.0029756569748682
ROE archetype: Standard Business
DuPont ROE decomposition for ACS.V (quarterly period ending 2024-11-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACS.V (quarterly period ending 2025-02-28)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACS.V (quarterly period ending 2025-08-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACS.V (quarterly period ending 2025-11-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACS.V (quarterly period ending 2026-02-28)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACT.DE (annual period ending 2022-12-31)
ROE: 20.708344182094752%
Net margin: 5.57390593906935%
Asset turnover: 1.2822754575982596
Equity multiplier (leverage): 2.897373000972963
EBIT margin: 5.599541148199172%
Interest burden factor: 1.3596601014425929
Tax burden factor: 0.7321108473426675
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ACT.DE (annual period ending 2023-12-31)
ROE: 22.94271497763953%
Net margin: 6.435228771347029%
Asset turnover: 1.3034864443042835
Equity multiplier (leverage): 2.7351068685919584
EBIT margin: 10.532896574302367%
Interest burden factor: 0.8462227373301022
Tax burden factor: 0.7219904957562929
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ACT.DE (annual period ending 2024-12-31)
ROE: 28.405959913835012%
Net margin: 9.787615633192658%
Asset turnover: 1.183224261614996
Equity multiplier (leverage): 2.4528189779419094
EBIT margin: 14.0962883707335%
Interest burden factor: 0.9643780559608838
Tax burden factor: 0.7199872582721686
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ACT.DE (annual period ending 2025-12-31)
ROE: 28.796462556190942%
Net margin: 11.319747738452095%
Asset turnover: 1.074721241957247
Equity multiplier (leverage): 2.367045245809149
EBIT margin: 16.538074949076258%
Interest burden factor: 0.9459462366748063
Tax burden factor: 0.7235779753917532
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ACV (annual period ending 2023-01-31)
ROE: -17.327487002679064%
Asset turnover: -0.10944477209537451
Equity multiplier (leverage): 1.5116100303384534
ROE archetype: Low Return
DuPont ROE decomposition for ACV (annual period ending 2024-01-31)
ROE: 39.186715901011446%
Net margin: 99.21375978445172%
Asset turnover: 0.260745935781025
Equity multiplier (leverage): 1.5147794775349188
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for ACV (annual period ending 2025-01-31)
ROE: 20.915475119445876%
Net margin: 99.10601576888853%
Asset turnover: 0.14235570514284032
Equity multiplier (leverage): 1.4824936455667457
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for ACV (annual period ending 2026-01-31)
ROE: 20.917654517632602%
Net margin: 98.58528847572671%
Asset turnover: 0.14883792435115384
Equity multiplier (leverage): 1.4255658047675142
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for AD.AS (quarterly period ending 2025-03-31)
ROE: 3.591572123176661%
Net margin: 2.380134043650112%
Asset turnover: 0.4521016238054541
Equity multiplier (leverage): 3.337698541329011
EBIT margin: 3.2995360027496132%
Interest burden factor: 0.94140625
Tax burden factor: 0.7662517289073306
ROE archetype: Low Return
DuPont ROE decomposition for AD.AS (quarterly period ending 2025-06-30)
ROE: 3.864821697766435%
Net margin: 2.373116230729257%
Asset turnover: 0.47832925731510556
Equity multiplier (leverage): 3.404736507026338
EBIT margin: 3.2305560367226747%
Interest burden factor: 0.92627345844504
Tax burden factor: 0.7930535455861071
ROE archetype: Low Return
DuPont ROE decomposition for AD.AS (quarterly period ending 2025-09-30)
ROE: 4.176052057635239%
Net margin: 2.596247888325776%
Asset turnover: 0.45899565368212697
Equity multiplier (leverage): 3.504379849118667
EBIT margin: 3.525384546990309%
Interest burden factor: 0.9432534678436318
Tax burden factor: 0.7807486631016043
ROE archetype: Low Return
DuPont ROE decomposition for AD.AS (quarterly period ending 2025-12-31)
ROE: 4.113055565456037%
Net margin: 2.456364410387399%
Asset turnover: 0.4788161073004678
Equity multiplier (leverage): 3.497059557329722
EBIT margin: 3.2992762877820345%
Interest burden factor: 0.9458064516129032
Tax burden factor: 0.7871759890859481
ROE archetype: Low Return
DuPont ROE decomposition for AD.AS (quarterly period ending 2026-03-31)
ROE: 3.765604747936422%
Net margin: 2.478003232178129%
Asset turnover: 0.44499474913904563
Equity multiplier (leverage): 3.4148999008840186
EBIT margin: 3.5149937152091937%
Interest burden factor: 0.9144316730523627
Tax burden factor: 0.770949720670391
ROE archetype: Low Return
DuPont ROE decomposition for ADBE (annual period ending 2022-11-30)
ROE: 33.848124688634265%
Net margin: 27.013518118823125%
Asset turnover: 0.64811338118903
Equity multiplier (leverage): 1.9333143548501885
EBIT margin: 34.635919572872886%
Interest burden factor: 0.9852410626434897
Tax burden factor: 0.7916111850865513
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ADBE (annual period ending 2023-11-30)
ROE: 35.51310150806373%
Net margin: 27.96640733680251%
Asset turnover: 0.6816872717055352
Equity multiplier (leverage): 1.8628021852203211
EBIT margin: 34.262455561852754%
Interest burden factor: 1.022406015037594
Tax burden factor: 0.7983526989263127
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ADBE (annual period ending 2024-11-30)
ROE: 36.312575515135684%
Net margin: 25.854452452917926%
Asset turnover: 0.7167258244596644
Equity multiplier (leverage): 1.9596055252587925
EBIT margin: 35.99627993489886%
Interest burden factor: 0.8953623562847177
Tax burden factor: 0.8021930457365459
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ADBE (annual period ending 2025-11-30)
ROE: 55.42599502487562%
Net margin: 29.99705498758888%
Asset turnover: 0.7959347687774169
Equity multiplier (leverage): 2.3214396766169156
EBIT margin: 36.62754007320459%
Interest burden factor: 1.0032161727544222
Tax burden factor: 0.8163498969544309
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ADEN.TO (annual period ending 2022-12-31)
ROE: 25.379705388068768%
Net margin: 4.987966977416374%
Asset turnover: 1.8051888977686088
Equity multiplier (leverage): 2.8186448166762657
EBIT margin: 7.622671703168902%
Interest burden factor: 0.8277899833190935
Tax burden factor: 0.7904896479695276
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ADEN.TO (annual period ending 2023-12-31)
ROE: 7.075671277837141%
Net margin: 1.609771520333815%
Asset turnover: 1.710018310535415
Equity multiplier (leverage): 2.5704114537440357
EBIT margin: 4.122002890157922%
Interest burden factor: 0.4647527219543903
Tax burden factor: 0.8402993076761696
ROE archetype: Standard Business
DuPont ROE decomposition for ADEN.TO (annual period ending 2024-12-31)
ROE: 7.711985542170341%
Net margin: 2.1278621847785377%
Asset turnover: 1.5987562306417766
Equity multiplier (leverage): 2.266942267892273
EBIT margin: 4.436655376791569%
Interest burden factor: 0.5705824080571265
Tax burden factor: 0.8405613628965167
ROE archetype: Standard Business
DuPont ROE decomposition for ADEN.TO (annual period ending 2025-12-31)
ROE: 10.708878679727519%
Net margin: 3.0422368897231364%
Asset turnover: 1.6587572815423828
Equity multiplier (leverage): 2.122111153468455
EBIT margin: 4.583317402210321%
Interest burden factor: 0.6406281828675636
Tax burden factor: 1.0361128355768212
ROE archetype: Standard Business
DuPont ROE decomposition for ADI1.DE (quarterly period ending 2025-03-31)
ROE: 1.6906170752324607%
Net margin: 1.0766194150367847%
Asset turnover: 0.46488154821488153
Equity multiplier (leverage): 3.3778529163144557
EBIT margin: 1.596985465637897%
Interest burden factor: 0.9662921348314607
Tax burden factor: 0.6976744186046512
ROE archetype: Low Return
DuPont ROE decomposition for ADI1.DE (quarterly period ending 2025-06-30)
ROE: 1.803661036115627%
Net margin: 1.0043290043290043%
Asset turnover: 0.5077552064391593
Equity multiplier (leverage): 3.536914269559687
EBIT margin: 1.9047619047619049%
Interest burden factor: 0.8
Tax burden factor: 0.6590909090909091
ROE archetype: Low Return
DuPont ROE decomposition for ADI1.DE (quarterly period ending 2025-09-30)
ROE: 2.736356648731745%
Net margin: 1.540858725761773%
Asset turnover: 0.4886839544820001
Equity multiplier (leverage): 3.6339738662567256
EBIT margin: 2.6662049861495842%
Interest burden factor: 0.8701298701298701
Tax burden factor: 0.664179104477612
ROE archetype: Low Return
DuPont ROE decomposition for ADI1.DE (quarterly period ending 2025-12-31)
ROE: 2.644727450317442%
Net margin: 1.4770057066129574%
Asset turnover: 0.5092606937373457
Equity multiplier (leverage): 3.5160787407490885
EBIT margin: 3.1050688150386034%
Interest burden factor: 0.6810810810810811
Tax burden factor: 0.6984126984126984
ROE archetype: Low Return
DuPont ROE decomposition for ADI1.DE (quarterly period ending 2026-03-31)
ROE: 1.9856151272472946%
Net margin: 1.2195121951219512%
Asset turnover: 0.4729620414160017
Equity multiplier (leverage): 3.4425688781875565
EBIT margin: 1.8911276069282432%
Interest burden factor: 1.0560747663551402
Tax burden factor: 0.6106194690265486
ROE archetype: Low Return
DuPont ROE decomposition for ADROITINFO.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.3751072179503725
ROE archetype: Standard Business
DuPont ROE decomposition for ADROITINFO.NS (quarterly period ending 2025-03-31)
ROE: -1.052007129437318%
Net margin: -7.550579076361188%
Asset turnover: 0.1078459216630941
Equity multiplier (leverage): 1.291917248176463
EBIT margin: -43.861790571387374%
ROE archetype: Low Return
DuPont ROE decomposition for ADROITINFO.NS (quarterly period ending 2025-06-30)
Net margin: 8.571370422004906%
EBIT margin: 8.931606101619026%
Interest burden factor: 1.3203828187307736
Tax burden factor: 0.7268099059452929
ROE archetype: Standard Business
DuPont ROE decomposition for ADROITINFO.NS (quarterly period ending 2025-09-30)
ROE: 1.0027964979803068%
Net margin: 6.715863287022058%
Asset turnover: 0.10979211964999687
Equity multiplier (leverage): 1.3600027677757789
EBIT margin: 6.871497145255352%
Interest burden factor: 1.3271408576154728
Tax burden factor: 0.7364333652924256
ROE archetype: Low Return
DuPont ROE decomposition for ADROITINFO.NS (quarterly period ending 2025-12-31)
Net margin: 10.638179064264627%
EBIT margin: 11.026265643867744%
Interest burden factor: 1.2094068494017851
Tax burden factor: 0.7977492802931171
ROE archetype: Standard Business
DuPont ROE decomposition for ADROITINFO.NS (quarterly period ending 2026-03-31)
ROE: 0.8704846269397649%
Net margin: 5.166252152286206%
Asset turnover: 0.11374348591687217
Equity multiplier (leverage): 1.481354402387998
EBIT margin: -0.6542950066960016%
Tax burden factor: 0.5142443631931749
ROE archetype: Low Return
DuPont ROE decomposition for ADX.AX (annual period ending 2022-12-31)
ROE: -21.251116271009707%
Net margin: -15.288918961921267%
Asset turnover: 0.48450248353421527
Equity multiplier (leverage): 2.868857396845399
EBIT margin: -2.404365921332893%
ROE archetype: Low Return
DuPont ROE decomposition for ADX.AX (annual period ending 2023-12-31)
ROE: -30.74518592168105%
Net margin: -30.585818497703965%
Asset turnover: 0.36245359089541374
Equity multiplier (leverage): 2.773349542661557
EBIT margin: -59.86188022219032%
ROE archetype: Low Return
DuPont ROE decomposition for ADX.AX (annual period ending 2024-12-31)
ROE: -39.24288160701314%
Net margin: -74.7620500160119%
Asset turnover: 0.21413397441892465
Equity multiplier (leverage): 2.451286711605414
EBIT margin: -74.23884607965275%
ROE archetype: Low Return
DuPont ROE decomposition for ADX.AX (annual period ending 2025-12-31)
ROE: -65.8168488739751%
Net margin: -109.30056096517968%
Asset turnover: 0.236552839073906
Equity multiplier (leverage): 2.5455787095220184
EBIT margin: -121.74937982049042%
ROE archetype: Low Return
DuPont ROE decomposition for ADY.V (quarterly period ending 2025-03-31)
ROE: -1.2764367598887967%
Asset turnover: 0
Equity multiplier (leverage): 1.0555441689481406
ROE archetype: Low Return
DuPont ROE decomposition for ADY.V (quarterly period ending 2025-06-30)
ROE: -1.8385216170813974%
Asset turnover: 0
Equity multiplier (leverage): 1.0455604611584903
ROE archetype: Low Return
DuPont ROE decomposition for ADY.V (quarterly period ending 2025-09-30)
ROE: -9.424292319442145%
Asset turnover: 0
Equity multiplier (leverage): 1.0285472987294535
ROE archetype: Low Return
DuPont ROE decomposition for ADY.V (quarterly period ending 2025-12-31)
ROE: -1.013418437889406%
Asset turnover: 0
Equity multiplier (leverage): 1.0266577900388942
ROE archetype: Low Return
DuPont ROE decomposition for ADY.V (quarterly period ending 2026-03-31)
ROE: -0.9975888015102057%
Asset turnover: 0
Equity multiplier (leverage): 1.0273184876787071
ROE archetype: Low Return
DuPont ROE decomposition for AEF.V (annual period ending 2024-09-30)
ROE: -20.00123390778596%
Asset turnover: 0
Equity multiplier (leverage): 1.047867396043269
ROE archetype: Low Return
DuPont ROE decomposition for AEF.V (annual period ending 2024-12-31)
Equity multiplier (leverage): 1.1899012926502488
ROE archetype: Standard Business
DuPont ROE decomposition for AEF.V (annual period ending 2025-09-30)
ROE: -58.91083568311628%
Asset turnover: 0
Equity multiplier (leverage): 1.6342108317588606
ROE archetype: Low Return
DuPont ROE decomposition for AEF.V (annual period ending 2025-12-31)
ROE: -66.1772933542289%
Asset turnover: 0
Equity multiplier (leverage): 1.2518211926032823
ROE archetype: Low Return
DuPont ROE decomposition for AEGISVOPAK.NS (annual period ending 2022-03-31)
Equity multiplier (leverage): 54.29115934356795
ROE archetype: Standard Business
DuPont ROE decomposition for AEGISVOPAK.NS (annual period ending 2023-03-31)
ROE: -0.015704566665544668%
Net margin: -0.021226495194321487%
Asset turnover: 0.19670438167729168
Equity multiplier (leverage): 3.761262392330206
EBIT margin: 39.333544654885486%
Interest burden factor: 0.018686410798831467
Tax burden factor: -0.02887947631882942
ROE archetype: Low Return
DuPont ROE decomposition for AEGISVOPAK.NS (annual period ending 2024-03-31)
ROE: 8.807512053639641%
Net margin: 15.405839850042987%
Asset turnover: 0.13940195038240774
Equity multiplier (leverage): 4.101087328841363
EBIT margin: 50.88480688406636%
Interest burden factor: 0.42336042203805474
Tax burden factor: 0.7151332859574608
ROE archetype: Standard Business
DuPont ROE decomposition for AEGISVOPAK.NS (annual period ending 2025-03-31)
ROE: 17.8675465929635%
Net margin: 28.489337657139313%
Asset turnover: 0.13852099079461264
Equity multiplier (leverage): 4.527588847623589
EBIT margin: 54.238651434766396%
Interest burden factor: 0.6199965892472515
Tax burden factor: 0.847196531955259
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for AEGISVOPAK.NS (annual period ending 2026-03-31)
ROE: 11.272526764554582%
Net margin: 37.04142292603162%
Asset turnover: 0.11610004295226718
Equity multiplier (leverage): 2.621206481709778
EBIT margin: 51.949390636676284%
Interest burden factor: 0.8476041819810295
Tax burden factor: 0.8412287620806851
ROE archetype: Standard Business
DuPont ROE decomposition for AEIN.DE (quarterly period ending 2025-03-31)
ROE: -0.009372998474284135%
Net margin: -0.01882156114393266%
Asset turnover: 0.20919692094331657
Equity multiplier (leverage): 2.380496873063564
EBIT margin: 2.3736079887070636%
Interest burden factor: -0.10176211453744492
ROE archetype: Low Return
DuPont ROE decomposition for AEIN.DE (quarterly period ending 2025-06-30)
ROE: -1.310188209131431%
Net margin: -2.5907701075103837%
Asset turnover: 0.20937656495889545
Equity multiplier (leverage): 2.4153314635263383
EBIT margin: 0.2980919920654926%
Interest burden factor: -8.110294117647058
ROE archetype: Low Return
DuPont ROE decomposition for AEIN.DE (quarterly period ending 2025-09-30)
ROE: 1.5285275634568487%
Net margin: 3.3406126423891873%
Asset turnover: 0.18840774714686198
Equity multiplier (leverage): 2.4285575398807966
EBIT margin: 5.839579767455586%
Interest burden factor: 0.6369516878916516
Tax burden factor: 0.8981275785464932
ROE archetype: Low Return
DuPont ROE decomposition for AEIN.DE (quarterly period ending 2025-12-31)
ROE: 12.487018206407331%
Net margin: 31.15513904451462%
Asset turnover: 0.18411175735581983
Equity multiplier (leverage): 2.176945355260976
EBIT margin: 15.345828664561473%
Interest burden factor: 0.7828576169930302
Tax burden factor: 2.593322734499205
ROE archetype: Standard Business
DuPont ROE decomposition for AEIN.DE (quarterly period ending 2026-03-31)
ROE: -0.9467433445947627%
Net margin: -2.1443696292727745%
Asset turnover: 0.21913811826727556
Equity multiplier (leverage): 2.014719941546207
EBIT margin: 0.5019214179280057%
Interest burden factor: -2.595982142857143
ROE archetype: Low Return
DuPont ROE decomposition for AERO.SW (annual period ending 2021-12-31)
ROE: -5.4162508523502755%
Net margin: -6.20326257005868%
Asset turnover: 0.44078376237181843
Equity multiplier (leverage): 1.9808565167082754
EBIT margin: -4.360852197070572%
ROE archetype: Low Return
DuPont ROE decomposition for AERO.SW (annual period ending 2022-12-31)
ROE: -3.8570294614589704%
Net margin: -2.764647425149334%
Asset turnover: 0.6477676961183899
Equity multiplier (leverage): 2.1537431855220888
EBIT margin: -2.0082931766572187%
ROE archetype: Low Return
DuPont ROE decomposition for AERO.SW (annual period ending 2023-12-31)
ROE: -4.196455882665791%
Net margin: -2.9874491084332795%
Asset turnover: 0.6411030393728119
Equity multiplier (leverage): 2.1910602003798756
EBIT margin: -0.17310217357763386%
ROE archetype: Low Return
DuPont ROE decomposition for AERO.SW (annual period ending 2024-12-31)
ROE: 3.738851529677836%
Net margin: 4.240650979700948%
Asset turnover: 0.4359268867370525
Equity multiplier (leverage): 2.0225163154708428
EBIT margin: 4.433477277400781%
Interest burden factor: 0.7205936920222634
Tax burden factor: 1.3273870825364131
ROE archetype: Low Return
DuPont ROE decomposition for AERO.SW (annual period ending 2025-12-31)
ROE: -0.3344673143939823%
Net margin: -0.30970121440044274%
Asset turnover: 0.6112135951536181
Equity multiplier (leverage): 1.7669235903005875
EBIT margin: 6.541404285170183%
Interest burden factor: 0.3111985264275233
Tax burden factor: -0.1521368378812199
ROE archetype: Low Return
DuPont ROE decomposition for AEVS.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.4432429832202036
ROE archetype: Standard Business
DuPont ROE decomposition for AEVS.SW (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.354929137339423
ROE archetype: Standard Business
DuPont ROE decomposition for AEVS.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.35775291573017
ROE archetype: Standard Business
DuPont ROE decomposition for AFA.AX (annual period ending 2021-06-30)
Net margin: -211.44538914323084%
Asset turnover: 0.07378987500603253
EBIT margin: -151.92936559843037%
ROE archetype: Standard Business
DuPont ROE decomposition for AFA.AX (annual period ending 2022-06-30)
Net margin: -184.63636363636365%
Asset turnover: 0.1038113783444001
EBIT margin: -81.63636363636364%
ROE archetype: Standard Business
DuPont ROE decomposition for AFA.AX (annual period ending 2023-06-30)
Net margin: -1182.889344262295%
Asset turnover: 0.058266809451640644
EBIT margin: -658.9139344262295%
ROE archetype: Standard Business
DuPont ROE decomposition for AFA.AX (annual period ending 2024-06-30)
Net margin: -345.55596876162144%
Asset turnover: 0.24969068386538168
EBIT margin: -110.82186686500557%
ROE archetype: Standard Business